Elizabeth A. Shephard

5.2k total citations
116 papers, 4.0k citations indexed

About

Elizabeth A. Shephard is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Elizabeth A. Shephard has authored 116 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 47 papers in Pharmacology and 30 papers in Oncology. Recurrent topics in Elizabeth A. Shephard's work include Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (27 papers) and Metabolism and Genetic Disorders (19 papers). Elizabeth A. Shephard is often cited by papers focused on Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (27 papers) and Metabolism and Genetic Disorders (19 papers). Elizabeth A. Shephard collaborates with scholars based in United Kingdom, United States and Belgium. Elizabeth A. Shephard's co-authors include Ian Phillips, Colin T. Dolphin, Azara Janmohamed, Robert L. Smith, Diede Fennema, Diana Hernandez, Mina Edwards, Brian R. Rabin, Flora Scott and Jeremy R. Everett and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Elizabeth A. Shephard

116 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth A. Shephard United Kingdom	35	1.8k	1.5k	825	496	441	116	4.0k
Abdellah Mansouri France	38	2.3k 1.3×	951 0.7×	527 0.6×	756 1.5×	423 1.0×	95	6.2k
Gerard J. Mulder Netherlands	41	2.5k 1.3×	1.4k 1.0×	1.0k 1.2×	246 0.5×	185 0.4×	179	5.1k
A. Guillouzo France	35	1.6k 0.9×	1.6k 1.1×	984 1.2×	244 0.5×	170 0.4×	116	4.8k
Denis M. Grant Canada	43	2.9k 1.6×	1.2k 0.8×	831 1.0×	241 0.5×	201 0.5×	90	5.3k
Yvonne Will United States	37	2.6k 1.4×	1.0k 0.7×	639 0.8×	518 1.0×	354 0.8×	84	5.3k
Dean W. Hum Canada	41	2.8k 1.5×	1.8k 1.2×	1.3k 1.6×	327 0.7×	257 0.6×	91	5.9k
Michael N. Berry Australia	25	2.4k 1.3×	661 0.5×	770 0.9×	1.4k 2.8×	736 1.7×	96	6.2k
A.E.M. McLean United Kingdom	34	1.3k 0.7×	1.2k 0.8×	520 0.6×	337 0.7×	285 0.6×	128	3.9k
Thomas H. Rushmore United States	40	3.8k 2.1×	2.0k 1.4×	1.1k 1.4×	350 0.7×	127 0.3×	68	6.9k
Kiyoshi Nagata Japan	44	2.5k 1.4×	2.7k 1.9×	1.5k 1.8×	393 0.8×	161 0.4×	231	6.6k

Countries citing papers authored by Elizabeth A. Shephard

Since Specialization

Citations

This map shows the geographic impact of Elizabeth A. Shephard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Shephard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Shephard more than expected).

Fields of papers citing papers by Elizabeth A. Shephard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Shephard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Shephard. The network helps show where Elizabeth A. Shephard may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Shephard

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Shephard. A scholar is included among the top collaborators of Elizabeth A. Shephard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Shephard. Elizabeth A. Shephard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanes, Lucy, Charlotte Tye, Jacques‐Donald Tournier, et al.. (2022). White Matter Disruptions Related to Inattention and Autism Spectrum Symptoms in Tuberous Sclerosis Complex. SSRN Electronic Journal. 1 indexed citations

Varshavi, Dorsa, Flora Scott, Ian Phillips, et al.. (2018). Metabolic Biomarkers of Ageing in C57BL/6J Wild-Type and Flavin-Containing Monooxygenase 5 (FMO5)-Knockout Mice. Frontiers in Molecular Biosciences. 5. 28–28. 16 indexed citations

Scott, Flora, et al.. (2017). Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut Bacteria. Drug Metabolism and Disposition. 45(9). 982–989. 29 indexed citations

Dona, Anthony C., Michael Kyriakides, Flora Scott, et al.. (2016). A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Computational and Structural Biotechnology Journal. 14. 135–153. 228 indexed citations

Bartlett, Mark J. & Elizabeth A. Shephard. (2016). The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care. Drug Metabolism and Personalized Therapy. 31(2). 91–96. 1 indexed citations

Melidoni, Anna N., Diana Hernandez, Bilal Omar, et al.. (2015). The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing. Biochemical Pharmacology. 96(3). 267–277. 39 indexed citations

Shephard, Elizabeth A., et al.. (2013). Detection of Regulatory Polymorphisms: High-Throughput Capillary DNase I Footprinting. Methods in molecular biology. 987. 269–282. 2 indexed citations

Sumner, Tom, Elizabeth A. Shephard, & I. David L. Bogle. (2012). A methodology for global-sensitivity analysis of time-dependent outputs in systems biology modelling. Journal of The Royal Society Interface. 9(74). 2156–2166. 59 indexed citations

Shephard, Elizabeth A. & Ian Phillips. (2010). The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism. Expert Opinion on Drug Metabolism & Toxicology. 6(9). 1083–1094. 13 indexed citations

10.

Hernandez, Diana, et al.. (2009). Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine. Pharmacogenetics and Genomics. 19(4). 289–299. 21 indexed citations

11.

Veeramah, Krishna R., Mark Thomas, Michael E. Weale, et al.. (2008). The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa. Pharmacogenetics and Genomics. 18(10). 877–886. 39 indexed citations

12.

Zhou, Jianhua & Elizabeth A. Shephard. (2006). Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3. Mutation Research/Reviews in Mutation Research. 612(3). 165–171. 34 indexed citations

13.

Janmohamed, Azara, et al.. (2006). Expression of Recombinant Flavin-Containing Monooxygenases in a Baculovirus/Insect Cell System. Humana Press eBooks. 320. 39–60. 5 indexed citations

14.

Wong, Siew Cheng, et al.. (2002). Transfection of Liver In Vivo by Biolistic Particle Delivery: Its Use in the Investigation of Cytochrome P450 Gene Regulation. Molecular Biotechnology. 20(2). 145–152. 16 indexed citations

15.

Smirlis, Despina, et al.. (2001). Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1. Biochemical Journal. 355(1). 71–71. 78 indexed citations

16.

Dolphin, Colin T., Azara Janmohamed, Robert L. Smith, Elizabeth A. Shephard, & Ian Phillips. (2000). Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome. Pharmacogenetics. 10(9). 799–807. 54 indexed citations

17.

Coecke, Sandra, et al.. (1998). Effect of Thyroid Hormones onFlavin-containing Monooxygenase Activity in Co-cultured Adult Rat Hepatocytes. Toxicology in Vitro. 12(4). 335–341. 3 indexed citations

18.

Ying, S C, Elizabeth A. Shephard, Frederick C. de Beer, et al.. (1992). Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. Molecular Immunology. 29(5). 677–687. 27 indexed citations

19.

Phillips, Ian, Elizabeth A. Shephard, Fumiko Mitani, & B. R. Rabin. (1981). Induction by phenobarbital of the mRNA for a specific variant of rat liver microsomal cytochrome P-450. Biochemical Journal. 196(3). 839–851. 47 indexed citations

20.

Stein, Gary, et al.. (1977). Evidence that the coupling of histone gene expression and DNA synthesis in HeLa S3 cells is not mediated at the transcriptional level. Biochemical and Biophysical Research Communications. 77(1). 245–252. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact